Cargando…
A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials
BACKGROUND: The past few decades have seen remarkable developments in dose-finding designs for phase I cancer clinical trials. While many of these designs rely on a binary toxicity response, there is an increasing focus on leveraging continuous toxicity responses. A continuous toxicity response pert...
Autor principal: | Lee, Se Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664620/ https://www.ncbi.nlm.nih.gov/pubmed/37990281 http://dx.doi.org/10.1186/s13063-023-07793-0 |
Ejemplares similares
-
A framework for handling missing accelerometer outcome data in trials
por: Tackney, Mia S., et al.
Publicado: (2021) -
Guidance for using pilot studies to inform the design of intervention trials with continuous outcomes
por: Bell, Melanie L, et al.
Publicado: (2018) -
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
por: Mozgunov, Pavel, et al.
Publicado: (2019) -
Registration of phase 3 crossover trials on ClinicalTrials.gov
por: Zeng, Lijuan, et al.
Publicado: (2020) -
Framework and Outcomes of a Critical Care Pharmacy Visiting Clinical Professor Program
por: Louzon, Patricia R., et al.
Publicado: (2020)